| Hans-Günter Meyer-Thompson | international
Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements.
Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements.
Spetz J, Hailer L, Gay C, Tierney M, Schmidt L, Phoenix B, Chapman S.
JAMA Netw Open. 2022 May 2;5(5):e225996. doi: 10.1001/jamanetworkopen.2022.5996. PMID: 35552728.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792222